ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
38 hedge funds and large institutions have $2.67M invested in Oncternal Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
86% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 14
Holders
38
Holding in Top 10
–
Calls
$47K
Puts
$54K
Top Buyers
| 1 | +$52.7K | |
| 2 | +$41.3K | |
| 3 | +$16K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$14K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.2K |
Top Sellers
| 1 | -$155K | |
| 2 | -$153K | |
| 3 | -$106K | |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$104K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$78K |